patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
repotrectinib
Marketedupdated 2mo agoby Bristol-Myers Squibb Co🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 1 investigational indication.
indications
investigational
NSCLC
targets
NT-3 growth factor receptorBDNF/NT-3 growth factors receptorCD74-ROS1High affinity nerve growth factor receptorProto-oncogene tyrosine-protein kinase ROS
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that